BSE: 544250 | NSE: SANOFICONR | Pharmaceuticals & Drugs |
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sanofi Consumer Healthcare India Ltd is a below average quality company.
The key valuation ratios of Sanofi Consumer Healthcare India Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sanofi Consumer Healthcare India Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
No data to display
Return on Equity has declined versus last 3 years average to 0.00%
Standalone | Consolidated | |
---|---|---|
TTM EPS (₹) | - | - |
TTM Sales (₹ Cr.) | - | - |
BVPS (₹.) ⓘ | - | - |
Reserves (₹ Cr.) ⓘ | - | - |
P/BV ⓘ | - | - |
PE ⓘ | - | - |
From the Market | |
---|---|
52 Week Low / High (₹) | 4479.00 / 5499.00 |
All Time Low / High (₹) | 4479.00 / 5499.00 |
Market Cap (₹ Cr.) | - |
Equity (₹ Cr.) | - |
Face Value (₹) | - |
Industry PE ⓘ | - |
Pledged * | 0.00 |